Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Recruiting	Not stated	2026-06-03		NCT07618078

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center	23
Cancer Hospital of Guizhou Province	8
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	294
Fujian Cancer Hospital	114
Hunan Cancer Hospital	66
Peking University Cancer Hospital & Institute	189
Sun Yat-Sen University Cancer Center	74
Xiangya Hospital of Central South University	162
Xijing Hospital	177

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Beijing	China	13